Microarray analysis reveals the potential molecular mechanism of Lp299v in stable coronary atherosclerotic disease

Zhenyang Fu1, Xiaolei Song2, Anna Shen1

  • 1Department of Cardiology, The Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, 510630, China.

AMB Express
|September 24, 2022
PubMed

Insights

Lactobacillus plantarum 299v (Lp299v) supplementation impacts gene expression related to inflammation and immune response in coronary artery disease. This probiotic may influence chemokine receptors, potentially affecting cellular processes.

Area of Science:

  • Molecular biology and immunology
  • Genomics and bioinformatics
  • Cardiovascular disease research

Background:

  • Inflammatory mechanisms are crucial in coronary atherosclerotic disease (CAD) development and treatment.
  • Circulating inflammatory cytokines are elevated in CAD patients, but underlying molecular mechanisms remain unclear.
  • The role of Lactobacillus plantarum 299v (Lp299v) supplementation in modulating these mechanisms is under investigation.

Purpose of the Study:

  • To identify differentially expressed genes (DEGs) associated with Lp299v supplementation.
  • To elucidate the molecular mechanisms and identify hub genes involved in Lp299v's effects on CAD.
  • To explore the impact of Lp299v on inflammatory and immune responses.

Main Methods:

  • Utilized a microarray dataset (GSE156357) from the Gene Expression Omnibus (GEO) database.
  • Analyzed differentially expressed genes (DEGs) using R software.
  • Performed Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, and protein-protein interaction (PPI) network analyses using DAVID, STRING, and Cytoscape.
  • Conducted weighted gene co-expression network analysis (WGCNA).

Main Results:

  • Identified thousands of DEGs in both daily and non-daily alcohol user groups.
  • GO analysis indicated up-regulation of miosis and down-regulation of immune response.
  • KEGG analysis revealed Lp299v reduced chemotactic cytokines and weakened immune response.
  • PPI network highlighted proteins involved in G protein-coupled receptor signaling, inflammatory response, cell proliferation, and apoptosis.
  • WGCNA identified 4 relevant DEG modules.

Conclusions:

  • Lp299v supplementation influences the expression of chemokine receptors and immune response regulation.
  • Chemokine receptors are suggested to play a cellular role in the context of Lp299v intervention.
  • Findings provide insights into the molecular effects of Lp299v in relation to inflammation and immune pathways relevant to CAD.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
25
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
25
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
44
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31